Browsing by Author Bellet Ezquerra, Meritxell
Showing results 2 to 9 of 9
< previous
Issue Date | Title | Author(s) |
---|---|---|
7-Sep-2022 | High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER<sup>+</sup> breast cancer | Palafox Sánchez, Marta; Monserrat Vicente, Laia; Bellet Ezquerra, Meritxell; Villacampa, Gullermo; González Pérez, Abel; Oliveira, Mafalda; Brasó Maristany, Fara; Ibrahimi, Nusaibah; Kannan, Srinivasaraghavan; Mina, Leonardo; Herrera Abreu, Maria Teresa; Odena, Andreu; Sánchez Guixé, Mònica; Capelán, Marta; Azaro, Analía; Bruna, Alejandra; Rodriguez, Olga; Guzmán, Marta; Grueso, Judit; Viaplana, Cristina; Hernandez, Javier; Su, Faye; Lin, Kui; Clarke, Robert; Caldas, Carlos; Arribas, Joaquín; Michiels, Stefan; García Sanz, Alicia; Turner, Nicholas, 1951-; Prat Aparicio, Aleix; Nuciforo, Paolo; Dienstmann, Rodrigo; Verma, Chandra S; López Bigas, Núria; Scaltriti, Maurizio; Arnedos, Monica; Saura, Cristina; Serra Elizalde, Violeta |
9-Jul-2021 | Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study | Gil Gil, Miguel; Bellet Ezquerra, Meritxell; Bergamino Sirvén, Milana; Morales, Serafín; Barnadas, Agustí; Manso, Luis; Saura, Cristina; Fernández Ortega, Adela; Garcia Martinez, Elena; Martinez Jañez, Noelia; Melé, Mireia; Villagrasa, Patricia; Celiz, Pamela; Perez Martin, X.; Ciruelos, Eva; Pernas, Sònia |
18-Sep-2019 | Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial | Adamo, Barbara; Bellet Ezquerra, Meritxell; Paré, Laia; Pascual, Tomás; Vidal Losada, Maria Jesús; Pérez Fidalgo, José A.; Blanch, Salvador; Martínez, Noelia; Murillo, Laura; Gómez Pardo, Patricia; López González, Ana; Amillano, Kepa; Canes, Jordi; Galván, Patricia; González Farré, Blanca; Gonzalez, Xavier; Villagrasa, Patricia; Ciruelos, Eva; Prat Aparicio, Aleix |
1-May-2019 | Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication | Bellet Ezquerra, Meritxell; Ahmad, Faten; Villanueva, Rafael; Valdivia, Carolina; Palomino Doza, Julián; Ruiz, Ada; Gonzalez-Farre, Xavier; Adrover, Encarna; Azaro, Analía; Valls Margarit, Maria; Parra, Josep Lluís; Aguilar Company, Juan; Vidal Losada, Maria Jesús; Martin, Anastasi; Gavilá, Joaquín; Escrivá de Romaní, Santiago; Perelló, Antonia; Hernando, Cristina; Lahuerta, Ainhara; Zamora, Pilar; Reyes, Victoria; Alcalde, María; Masanas, Helena; Celiz, Pamela; Ruiz, Isabel; Gil Gil, Miguel; Seguí, Miguel Àngel; Peña, Lorena de la |
27-Sep-2022 | Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial | Albanell Mestres, Joan; Pérez García, José Manuel; Gil Gil, Miguel; Curigliano, Giuseppe; Ruíz Borrego, Manuel; Comerma, Laura; Gibert, Joan; Bellet Ezquerra, Meritxell; Bermejo, Begoña; Calvo, Lourdes; Haba, Juan de la; Espinosa, Enrique; Minisini, Alessandro Marco; Quiroga Garcia, Vanesa; Santaballa Bertran, Ana; Mina, Leonardo; Bellosillo Paricio, Beatriz; Rojo, Federico; Menéndez, Silvia; Sampayo Cordero, Miguel; Popa, Crina; Malfettone, Andrea; Cortés, Javier; Llombart Cussac, Antonio |
3-Nov-2023 | Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer | Jhaveri, Komal L.; Bellet Ezquerra, Meritxell; Turner, Nicholas C.; Loi, Sherene; Bardia, Aditya; Boni, Valentina; Sohn, Joohyuk; Neilan, Tomas G.; Villanueva Vázquez, Rafael; Kabos, Peter; García Estévez, Laura; López Miranda, Elena; Pérez Fidalgo, J. Alejandro; Pérez García, Jose M.; Yu, Jiajie; Fredrickson, Jill; Moore, Heather M.; Chang, Ching-Wei; Bond, John W.; Eng-Wong, Jennifer; Gates, Mary R.; Lim, Elgene |
28-Sep-2022 | Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial | Salvador Bofill, Javier; Moreno Anton, Fernando; Rodríguez Sánchez, César A.; Galve Calvo, Elena; Hernando Melia, Cristina; Ciruelos, Eva; Vidal Losada, Maria Jesús; Jiménez Rodriguez, Begoña; De La Cruz Merino, Luis; Martínez Jañez, Noelia; Villanueva Vazquez, Rafael; De Toro Salas, Ruben; Anton Torres, Antonio; Alvarez Lopez, Isabel Manuela; Gavila Gregori, Joaquin; Quiroga Garcia, Vanesa; Vicente Rubio, Elena; De La Haba Rodriguez, Juan; Gonzalez Santiago, Santiago; Diaz Fernandez, Nieves; Barnadas Molins, Agusti; Cantos Sanchez De Ibargüen, Blanca; Delgado Mingorance, Juan Ignacio; Bellet Ezquerra, Meritxell; De Casa, Sonia; Gimeno, Asuncion; Martin, Miguel |
23-Apr-2021 | SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer | Pascual, Tomás; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavilá, Joaquin; Pernas, Sònia; Muñoz Mateu, Montserrat; Vidal Losada, Maria Jesús; Margelí Vila, Mireia; Cejalvo Andújar, Juan Miguel; González Farré, Blanca; Espinosa Bravo, Martin; Cruz, Josefina; Salvador Bofill, Francisco Javier; Guerra, Juan Antonio; Luna Barrera, Ana María; Arumi de Dios, Miriam; Esker, Stephen; Fan, Pang-dian; Martínez Sáez, Olga; Villacampa, Guillermo; Paré, Laia; Ferrero Cafiero, Juan M.; Villagrasa, Patricia; Prat Aparicio, Aleix |